Related Experiment Video

Updated: Jun 3, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors

Yan Zhao1, Xin Nie2, Hongbo Yan3

  • 1Special Care Ward, Jilin Province Cancer Hospital, Changchun, Jilin, People's Republic of China.

International Journal of Nanomedicine
|June 2, 2026
PubMed

Insights

Nanodrug delivery systems offer a promising approach to combat cancer metastasis by enhancing drug efficacy and reducing systemic toxicity. This review explores nanoparticle carriers, their advantages, and targeting capabilities for improved cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Cancer metastasis is a leading cause of mortality worldwide.
  • Conventional cancer therapies often suffer from systemic toxicity.
  • Nanodrug delivery systems present a novel therapeutic strategy.

Purpose of the Study:

  • To review nanoparticle drug delivery systems for cancer treatment.
  • To highlight the advantages and targeting capabilities of nanocarriers.
  • To provide a basis for improving nanomedicine and clinical translation.

Main Methods:

  • Review of existing literature on nanodrug delivery systems.
  • Analysis of inorganic and organic nanocarrier compositions.
  • Focus on tumor-targeting properties of nanoparticles.

Main Results:

  • Nanocarriers improve solubility and stability of hydrophobic drugs.
  • Nanoparticles enhance drug circulation time and tumor targeting.
  • Nanodrug delivery systems synergistically improve efficacy and reduce toxicity.

Conclusions:

  • Nanodrug delivery systems are effective in enhancing cancer treatment outcomes.
  • Targeting capabilities of nanoparticles are crucial for efficacy.
  • Further development is needed to accelerate clinical translation of nanomedicines.
Keywords:
cancernanomaterialsnanomedicinesubcellular organellestargeting tumors

More Related Videos

Manufacture and Drug Delivery Applications of Silk Nanoparticles09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.